Events

MSCA Presidency Conference 2026: Celebrating Mobility, Shaping Resilience
NOV
Wed
04
NOV
Thu
05

Starts in 1 month from now

Location

Dublin, Ireland

Technological University of Dublin
Dublin
Ireland
Programmes
MSCA

The 2026 Marie Skłodowska-Curie Actions (MSCA) Presidency Conference will focus on resilient research careers as the central unifying policy lens through which levers such as the triple-i mobility dimensions of collaboration and attractiveness are examined.

The MSCA Presidency Conference 2026, which coincides with the 30th anniversary of the MSCA, will be on the theme of Resilient Research Careers.

The conference will focus on how the MSCA and European institutions can reinforce Europe’s capacity to attract, retain, and empower researchers by supporting stable, sustainable, and globally connected research careers. It will ask the question how researchers can be better supported in the face of uncertainty, including the geopolitical environment, and a rapidly changing labour market.

It will also examine the past, present, and future of the MSCA in light of Europe’s evolving research and innovation ecosystem.

The conference will bring together early-career researchers, policymakers, university leaders, government officials and industry representatives from across Europe. It will build on the annual MSCA conference in Denmark in 2025 and provide a bridge to continued policy dialogue in 2027 in Lithuania.

Ireland’s Presidency of the Council of the European Union coincides with critical discussions and planning on the next European Research Framework Programme, FP10 (2028-2034). The conference will provide a valuable opportunity to consider how Europe can further support the development of resilient research careers as part of FP10.

It will help inform and shape European research policy, strengthen networks and cultivate a space for reflection. The conference will also consider what has been achieved to date and catalyse new ideas to chart the future of the MSCA for the next 30 years.

All informatio0n related to the conference, including the programme, registration, conference venue and video livestream, is available on the conference webpage.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Event calendar

 

Testimonial

Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe

The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.